BUZZ-Street View: CVS powers its turnaround score amid Medicare pressure

Reuters

Feb 11

BUZZ-Street View: CVS powers its turnaround score amid Medicare pressure

** Health insurer CVS Health CVS.N on Tuesday reaffirmed the 2026 earnings and revenue outlook it issued in December, while suggesting it could surpass those targets as its turnaround gains traction

** Median PT of 29 brokerages covering the stock is $95 - data compiled by LSEG

CVS RIDES THE MEDICARE WAVE

** Truist Securities ("buy," PT: $98) says CVS is well-positioned on the regulatory front due to its transparency and affordability efforts, and remains upbeat about the co's integrated offerings and momentum heading into 2026

** Morgan Stanley ("overweight," PT: $93) says CVS keeping its FY26 guidance shows the turnaround remains on track despite uncertainty for managed-care firms

** RBC Capital Markets ("outperform," PT: $93) says it sees CVS as the best-positioned managed-care firm, citing momentum in its Medicare Advantage margins and its strong 2026 Stars ratings

** BofA Global Research ("buy," PO: $95) says CVS has several ways to support overall growth and adds that it remains positive on its long-term strategy

(Reporting by Kanishka Ajmera in Bengaluru)

((Kanishka.Ajmera@thomsonreuters.com))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/news/2610937152"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2610937152\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2610937152?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-02-11 20:52","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2610937152","market":"nz","top_or_hot":-1,"title":"BUZZ-Street View: CVS powers its turnaround score amid Medicare pressure","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BUZZ-Street View: CVS powers its turnaround score amid Medicare pressure</title></head><body><p>** Health insurer CVS Health <span>CVS.N</span> on Tuesday <span>reaffirmed</span> the 2026 earnings and revenue outlook it issued in December, while suggesting it could surpass those targets as its turnaround gains traction</p><p>** Median PT of 29 brokerages covering the stock is $95 - data compiled by LSEG</p><p>CVS RIDES THE MEDICARE WAVE</p><p>** Truist Securities (\"buy,\" PT: $98) says CVS is well-positioned on the regulatory front due to its transparency and affordability efforts, and remains upbeat about the co's integrated offerings and momentum heading into 2026</p><p>** <a href=\"https://laohu8.com/S/MSPQL\">Morgan Stanley</a> (\"overweight,\" PT: $93) says CVS keeping its FY26 guidance shows the turnaround remains on track despite uncertainty for managed-care firms</p><p>** RBC Capital Markets (\"outperform,\" PT: $93) says it sees CVS as the best-positioned managed-care firm, citing momentum in its Medicare Advantage margins and its strong 2026 Stars ratings </p><p>** BofA Global Research (\"buy,\" PO: $95) says CVS has several ways to support overall growth and adds that it remains positive on its long-term strategy</p><p> (Reporting by Kanishka Ajmera in Bengaluru)</p><p> ((Kanishka.Ajmera@thomsonreuters.com))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BUZZ-Street View: CVS powers its turnaround score amid Medicare pressure</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBUZZ-Street View: CVS powers its turnaround score amid Medicare pressure\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2026-02-11 20:52</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BUZZ-Street View: CVS powers its turnaround score amid Medicare pressure</title></head><body><p>** Health insurer CVS Health <span>CVS.N</span> on Tuesday <span>reaffirmed</span> the 2026 earnings and revenue outlook it issued in December, while suggesting it could surpass those targets as its turnaround gains traction</p><p>** Median PT of 29 brokerages covering the stock is $95 - data compiled by LSEG</p><p>CVS RIDES THE MEDICARE WAVE</p><p>** Truist Securities (\"buy,\" PT: $98) says CVS is well-positioned on the regulatory front due to its transparency and affordability efforts, and remains upbeat about the co's integrated offerings and momentum heading into 2026</p><p>** <a href=\"https://laohu8.com/S/MSPQL\">Morgan Stanley</a> (\"overweight,\" PT: $93) says CVS keeping its FY26 guidance shows the turnaround remains on track despite uncertainty for managed-care firms</p><p>** RBC Capital Markets (\"outperform,\" PT: $93) says it sees CVS as the best-positioned managed-care firm, citing momentum in its Medicare Advantage margins and its strong 2026 Stars ratings </p><p>** BofA Global Research (\"buy,\" PO: $95) says CVS has several ways to support overall growth and adds that it remains positive on its long-term strategy</p><p> (Reporting by Kanishka Ajmera in Bengaluru)</p><p> ((Kanishka.Ajmera@thomsonreuters.com))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4588","symbol_name":"碎股","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260211:nL6N3Z70MS:1","article_id":"2610937152","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2610937152","pubTimestamp":1770814346,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"BUZZ-Street View: CVS powers its turnaround score amid Medicare pressure** Health insurer CVS Health CVS.N on Tuesday reaffirmed the 2026 earnings and revenue outlook it issued in December, while suggesting it could surpass those targets as its turnaround gains traction** Median PT of 29 brokerages covering the stock is $95 - data compiled by LSEGCVS RIDES THE MEDICARE WAVE** Truist Securities  says CVS is well-positioned on the regulatory front due to its transparency and affordability efforts, and remains upbeat about the co's integrated offerings and momentum heading into 2026** Morgan Stanley  says CVS keeping its FY26 guidance shows the turnaround remains on track despite uncertainty for managed-care firms** RBC Capital Markets  says it sees CVS as the best-positioned managed-care firm, citing momentum in its Medicare Advantage margins and its strong 2026 Stars ratings ** BofA Global Research  says CVS has several ways to support overall growth and adds that it remains positive on","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4588":"碎股","BK4550":"红杉资本持仓","IE00BZ1G4Q59.USD":"LEGG MASON CLEARBRIDGE US EQUITY SUSTAINABILITY LEADER \"A\"(USD) INC (A)","IE00BKVL7J92.USD":"Legg Mason ClearBridge - US Equity Sustainability Leaders A Acc USD","LU0320765489.SGD":"FTIF - Franklin Mutual US Value A Acc SGD","LU1571399168.USD":"ALLSPRING GLOBAL LONG/SHORT EQUITY \"IP\" (USD) ACC","LU0211331839.USD":"FRANKLIN MUTUAL GLB DISCOVERY \"A\" (USD) ACC","BK4196":"保健护理服务","LU1059921491.USD":"NORDEA 1 GLOBAL STABLE EQUITY \"HB\" (USDHDG) ACC","BK4581":"高盛持仓","LU0061475181.USD":"THREADNEEDLE (LUX) AMERICAN \"AU\" (USD) ACC","LU0432979614.USD":"JPM GLOBAL HEALTHCARE \"A\" ACC","LU1699723380.USD":"ALLSPRING GLOBAL LONG/SHORT EQUITY \"AP\" (USD) ACC","LU0006061336.USD":"Blackrock US Small and MidCap Opportunities A2 USD","IE00B19Z3581.USD":"Legg Mason ClearBridge - Value A Acc USD","BK4585":"ETF&股票定投概念","LU0208291251.USD":"FRANKLIN MUTUAL U.S. VALUE \"A\" (USD) INC","LU0070302665.USD":"FRANKLIN MUTUAL U.S. VALUE \"A\" (USD) ACC","IE00B19Z3B42.SGD":"Legg Mason ClearBridge - Value A Acc SGD","IE00B7SZLL34.SGD":"Legg Mason ClearBridge - Value A Acc SGD-H","LU0162691827.USD":"BGF US BASIC VALUE \"A4\" INC","LU1983299246.USD":"SCHRODER ISF HEALTHCARE INNOVATION \"A\" (USD) ACC","CVS":"西维斯健康","IE0002270589.USD":"LEGG MASON CLEARBRIDGE VALUE \"A\" (USD) INC","IE00BSNM7G36.USD":"NEUBERGER BERMAN SYSTEMATIC GLOBAL SUSTAINABLE VALUE \"A\" (USD) ACC","LU0072461881.USD":"BGF US BASIC VALUE \"A2\" ACC","BK4504":"桥水持仓"},"translate_title":"BUZZ街景：CVS在医疗保险压力下提高了其扭亏为盈分数","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"CVS":0.9},"content_text":"BUZZ-Street View: CVS powers its turnaround score amid Medicare pressure** Health insurer CVS Health CVS.N on Tuesday reaffirmed the 2026 earnings and revenue outlook it issued in December, while suggesting it could surpass those targets as its turnaround gains traction** Median PT of 29 brokerages covering the stock is $95 - data compiled by LSEGCVS RIDES THE MEDICARE WAVE** Truist Securities (\"buy,\" PT: $98) says CVS is well-positioned on the regulatory front due to its transparency and affordability efforts, and remains upbeat about the co's integrated offerings and momentum heading into 2026** Morgan Stanley (\"overweight,\" PT: $93) says CVS keeping its FY26 guidance shows the turnaround remains on track despite uncertainty for managed-care firms** RBC Capital Markets (\"outperform,\" PT: $93) says it sees CVS as the best-positioned managed-care firm, citing momentum in its Medicare Advantage margins and its strong 2026 Stars ratings ** BofA Global Research (\"buy,\" PO: $95) says CVS has several ways to support overall growth and adds that it remains positive on its long-term strategy (Reporting by Kanishka Ajmera in Bengaluru) ((Kanishka.Ajmera@thomsonreuters.com))","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}